PERSON DIRECTORY
Molly O'Shea
Host of Sourcery. Molly O'Shea appears in 53 indexed conversations across Sourcery. This directory brings every appearance, source, TL;DR, digest, and transcript into one searchable feed.
Dylan Patel, SemiAnalysis
Permits have pushed gigawatts of capacity from 2027 into 2028, while Patel sees no space-based relief for three or four years.Persistent agents now take 45% of his company’s $15 million annual AI spend, mostly via Perplexity Computer using Claude and OpenAI.Better harnesses can redirect usage, but Harvey’s fluctuating margins and uncertain Perplexity take leave durable economics unresolved.
Dylan Patel's SemiAnalysis Empire: $500M Fund, Citrini & NVIDIA?
SemiAnalysis shifted multiple gigawatts of data-center capacity from 2027 into 2028 as permits remain unavailable, while Patel expects space to add little capacity before “maybe 2030.”Patel says new very high-end chips will not be approved for China, and scrutiny could extend to GPU rentals; rental access may preserve demand while shifting business toward approved providers or AMD.Persistent agents rose to 45% of SemiAnalysis’s $50 million annual AI spend, mostly through Perplexity Computer using Claude and OpenAI, but margins and customer retention remain unresolved.
SpaceX, Palantir, Anduril & Onodrim | The Return of Conglomerates
SpaceX’s roughly 160% Q3 revenue growth and sub-12-month compute paybacks bolster Garrett’s view of a vertically integrated hyperscaler with several growth engines.He places SpaceX at roughly 20–30× EBITDA on a $2 trillion valuation, while arguing that ownership across applications, models and infrastructure offers flexibility as AI economics shift.The thesis still hinges on uncertain future demand and financing; Starship’s expected order-of-magnitude launch-cost reduction could open new businesses, but full reusability remains a key economic milestone.
Inside $17B Index Ventures: Anthropic, Wiz, Datadog & the Future of AI
Bloomberg’s January 2026 figures put Index’s 2012 fund at 11X DPI versus a 1.5X industry average, and its $780 million 2015 growth fund at 5.1X.Shah says a roughly 25% valuation gap should not stop a deal; with model advances every few months unsettling AI retention, adaptable founders become central to durability.
Franklin Templeton CEO on SpaceX, Anthropic, Circular Deals & the State of the Market
Johnson favors shorter-term AI financing: today’s cash-generative borrowers differ from internet-bubble firms, but 20- or 30-year data-center debt risks locking in current chip and energy needs.Franklin Templeton’s late-stage SpaceX and Anthropic stakes seek missed IPO returns, but illiquid holdings may stay at 6%, 7% or 8% against a 15% limit.
Apollo’s Yahoo Playbook, 5 Years After the $5B Deal
Lanzone says Apollo has largely recovered its $4.8 billion Yahoo cost through early cash returns and disposals including AOL.The reset shut loss-making ad tech that cost hundreds of millions annually and opened inventory to competing demand, while retaining DSP.Scout restores owned search, but Lanzone makes no IPO commitment and hesitates to call Yahoo’s audience distribution a moat.
Thrive Capital’s Dr. Nworah Ayogu on Why Neuralink Is More Interesting Than SpaceX
Thrive’s healthcare thesis is that AI may shift bottlenecks from molecule generation to validation, trials, manufacturing, and commercialization.Cadence cites 25% fewer hospitalizations, over-80% more controlled-blood-pressure patients, nearly one-point lower A1C, and $2.5 million in weekly Medicare savings across 100,000+ monitored patients.Neuralink and OpenAI show upside, while clinical processes and manufacturing capacity remain unresolved constraints.
USV’s New $900M Fund: Fred Wilson, Rebecca Kaden & Mike Mignano
Fred WilsonRebecca KadenMichael MignanoMolly O'Shea
USV’s $900 million fund targets 30-40 companies with $10 million-$30 million Series A checks as larger rounds and scaling costs reshape venture.Its AI thesis spans applications, infrastructure, physical AI, and energy, while usage retention, compute costs, inference subsidies, distribution, interoperability, trust, and leadership concentration remain key tests.
Annie Lamont: $14B Managed, 70+ Exits, 15 IPOs, 7x Midas Investor
Jonathan SiddharthMolly O'Shea
Healthcare AI has crossed O'Shea’s threshold for measurable impact, with biological and chemical models, laboratory robotics and simulations targeting drug development’s high failure rates.After a decade building licenses, networks and care infrastructure, Devoted Health tripled in size, halved operating expenses and significantly increased EBITDA, while China’s rising pharmaceutical research share leaves domestic research and regulatory capacity as risks to monitor.
Bending Spoons Is Coming for Silicon Valley, with CEO Luca Ferrari
Bending Spoons’ edge is an integrated operating model that standalone owners cannot economically reproduce.Its 50-plus proprietary technologies, nearly 1,000-person core team, and debt-funded permanent ownership support claimed annual savings above $100 million and $4 million revenue per core Spooner.Airtable’s approximately $1.3 billion enterprise value reflects the underwriting test, while AI startup valuations and unmeasured AI capabilities remain key risks to monitor.









